ACADIA Pharmaceuticals, Inc. (ACAD)

26.52 -0.34 (-1.28%) USD  |  NASDAQ  |  Jan 15, 16:00
26.52 0.00 (0.00%) After-Hours: 17:54
More

ACADIA Pharmaceuticals SG&A Expense (TTM): 523.36M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. 353.07M
ANI Pharmaceuticals, Inc. 304.67M
Catalyst Pharmaceuticals, Inc. 162.44M
Regeneron Pharmaceuticals, Inc. 2.717B
Vanda Pharmaceuticals, Inc. 214.26M